KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on SalesTimes Interest Earned

Aurora Cannabis (ACB) EBIT Margin (2017 - 2025)

Aurora Cannabis has reported EBIT Margin over the past 9 years, most recently at 20.77% for Q4 2025.

  • Quarterly EBIT Margin fell 2102.0% to 20.77% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.36% through Dec 2025, down 988.0% year-over-year, with the annual reading at 1.44% for FY2025, 1817.0% up from the prior year.
  • EBIT Margin was 20.77% for Q4 2025 at Aurora Cannabis, up from 4.34% in the prior quarter.
  • Over five years, EBIT Margin peaked at 41.79% in Q4 2024 and troughed at 167.1% in Q1 2021.
  • The 5-year median for EBIT Margin is 26.94% (2023), against an average of 44.74%.
  • Year-over-year, EBIT Margin surged 808245bps in 2021 and then crashed -5920bps in 2022.
  • A 5-year view of EBIT Margin shows it stood at 80.73% in 2021, then tumbled by -36bps to 109.59% in 2022, then skyrocketed by 75bps to 27.33% in 2023, then skyrocketed by 253bps to 41.79% in 2024, then tumbled by -50bps to 20.77% in 2025.
  • Per Business Quant, the three most recent readings for ACB's EBIT Margin are 20.77% (Q4 2025), 4.34% (Q3 2025), and 1.54% (Q2 2025).